Our Mission
Our laboratory is interested in how microbial-triggered inflammation protects against pathogens and yet can paradoxically harm the host through secondary effects such as tissue fibrosis and carcinogenesis. The genitourinary tract is our model system. We are examining anti-pathogenic inflammation induced by bacteria such as uropathogenic E. coli. Chronic infection-mediated tissue fibrosis and carcinogenesis are being studied using models of Schistosoma haematobium. Through our research, we seek to better understand microbial-triggered inflammation and harness its potential for human benefit.
Besides studying the basic biology of genitourinary inflammation and infection, we are also collaborating with the CHARM lab at Stanford to develop better minimally invasive surgical techniques for children with conditions predisposing them to urinary tract infections.
We are part of the Stanford Department of Urology and an affiliated member of the Bio-X, Stanford Immunology, and Institute for Immunity, Transplantation, and Infection interdisciplinary programs at Stanford. More »
A Mother's Day for All:
This Mother’s Day leads me to not only reflect on the fortunes of my own family, but also the misfortunes of other mothers.
HIV and Female Genital Schistosomiasis: The Hidden Human Cost:
...public health advocates have called for deworming as a cost-effective strategy to reduce risk of contracting HIV in regions endemic for S. haematobium and HIV
The Most Neglected of the Neglected:
Urogenital infection by Schistosoma haematobium remains an understudied disease, even by neglected tropical disease standards
A Schistosoma haematobium miracidium inside its egg






